Jeffrey Eisele

Insider Reports History

Location
Waltham, MA
Signature
/s/ David Watson, attorney-in-fact for Jeffrey Eisele
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey Eisele:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Chief Development Officer Common Stock 55,312 $1,633,009 $29.52 29 Jan 2025 Direct

Insider Reports Filed by Jeffrey Eisele

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 29 Jan 2025 1 -$8,207 4 Chief Development Officer 30 Jan 2025, 12:10
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2025 1 -$39,279 4 Chief Development Officer 23 Jan 2025, 15:26
APLS Apellis Pharmaceuticals, Inc. 13 Jan 2025 1 -$7,577 4 Chief Development Officer 14 Jan 2025, 16:15
APLS Apellis Pharmaceuticals, Inc. 23 Dec 2024 1 -$2,084 4 Chief Development Officer 27 Dec 2024, 16:06
APLS Apellis Pharmaceuticals, Inc. 29 Jan 2024 2 -$81,524 4 Chief Development Officer 31 Jan 2024, 16:23
APLS Apellis Pharmaceuticals, Inc. 23 Jan 2024 1 -$469,904 4 Chief Development Officer 24 Jan 2024, 16:03
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2024 1 -$104,448 4 Chief Development Officer 23 Jan 2024, 18:05
APLS Apellis Pharmaceuticals, Inc. 17 Jan 2024 1 -$341,475 4 Chief Development Officer 18 Jan 2024, 16:55
APLS Apellis Pharmaceuticals, Inc. 16 Jan 2024 3 $1,851,469 4 Chief Development Officer 17 Jan 2024, 12:24
APLS Apellis Pharmaceuticals, Inc. 26 Dec 2023 2 -$18,088 4 Chief Development Officer 28 Dec 2023, 16:13
APLS Apellis Pharmaceuticals, Inc. 23 Feb 2023 1 -$113,178 4 Chief Development Officer 27 Feb 2023, 15:34
APLS Apellis Pharmaceuticals, Inc. 21 Feb 2023 3 -$48,262 4 Chief Development Officer 22 Feb 2023, 05:46
APLS Apellis Pharmaceuticals, Inc. 30 Jan 2023 1 -$46,587 4 Chief Development Officer 31 Jan 2023, 15:51
APLS Apellis Pharmaceuticals, Inc. 27 Jan 2023 1 -$19,366 4 Chief Development Officer 30 Jan 2023, 15:58
APLS Apellis Pharmaceuticals, Inc. 23 Jan 2023 1 -$231,026 4 Chief Development Officer 25 Jan 2023, 15:14
APLS Apellis Pharmaceuticals, Inc. 20 Jan 2023 1 -$105,817 4 Chief Development Officer 24 Jan 2023, 16:15
APLS Apellis Pharmaceuticals, Inc. 12 Jan 2023 2 $1,867,955 4 Chief Development Officer 17 Jan 2023, 18:35
APLS Apellis Pharmaceuticals, Inc. 25 Apr 2022 2 -$4,599 4 Exec VP, Program Team Lead 23 Dec 2022, 15:15
APLS Apellis Pharmaceuticals, Inc. 28 Jan 2022 1 -$16,748 4 Exec VP, Program Team Lead 01 Feb 2022, 17:09
APLS Apellis Pharmaceuticals, Inc. 21 Jan 2022 2 $0 4 Exec VP, Program Team Lead 25 Jan 2022, 15:50
APLS Apellis Pharmaceuticals, Inc. 22 Dec 2021 1 -$4,255 4 Exec VP, Program Team Lead 23 Dec 2021, 15:49